⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

June 24, 2024Journal of Medicinal Chemistry

Novel Bifunctional Conjugates Targeting PD-L1/PARP7 as Dual Immunotherapy for Potential Cancer Treatment

Yuan Gao Ji‐Long Duan Chenchen Wang Yinghui Yuan Pengpeng Zhang Zong-Hao Wang Bowen Sun Jiawei Zhou Xiaoli Du Xiawen Dang Rui-Ting Bai Hang Zhang Tian Xie Xiang‐Yang Ye

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Bifunctional conjugates targeting PD-L1/PARP7 were designed, synthesized, and evaluated for the first time. Compounds

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gao et al. (2024) studied this question.

synapsesocial.com/papers/68e637f1b6db6435875c978c https://doi.org/10.1021/acs.jmedchem.4c00296

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Discovery of Small and Bifunctional Molecules Targeting PD-L1/CD73 for Cancer Dual Immunotherapy2024 · 22 citations
2PARP1 and PD-L1 dual-targeted bifunctional small-molecule inhibitors: a novel strategy for dual immunotherapy of triple-negative breast cancerOriginal Research · 2026
3Dual PARP and RAD51 Inhibitory Drug Conjugates Show Synergistic and Selective Effects on Breast Cancer CellsOriginal Research · 2021 · 23 citations
4Nonsymmetrically Substituted 1,1′-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction2024 · 11 citations
5Combining Data-Driven and Structure-Based Approaches in Designing Dual PARP1-BRD4 Inhibitors for Breast Cancer Treatment2024 · 9 citations
64-Arylindolines Bearing a Pyrido[3,2- <i>d</i> ]pyrimidine Scaffold as Dual Inhibitors of the PD-1/PD-L1 Interaction and NAMPT for Targeting Tumor Immunoevasion and MetabolismIn Vitro Study · 2026
7Discovery of Novel Proteolysis-Targeting Chimera Molecules as Degraders of Programmed Cell Death-Ligand 1 for Breast Cancer Therapy2024 · 15 citations
8Abstract 4567: A novel PARP7 inhibitor exhibits dual antitumor activity through immune activation and tumor-intrinsic growth inhibitionOriginal Research · 2026
9Lipid-Modified CGRP Receptor Antagonists: Balancing Pharmacokinetic Improvement and Potency LossJournal of Medicinal Chemistry · 2026
10Discovery of F73, a New Generation RET Inhibitor Overcoming RET Gatekeeper (V804M) and Solvent-Front (G810C/R) MutationsJournal of Medicinal Chemistry · 2026

More from Journal of Medicinal Chemistry

More from Hangzhou Normal University

More from Shanghai University of Traditional Chinese Medicine